The University of Michigan on Monday announced it will no longer provide transgender-identifying minors with “puberty blockers and gender affirming hormones.”

The university released a statement revealing that its medical center, Michigan Medicine, is suspending such treatments for patients under the age of 19 due to a Department of Justice subpoena issued to the school in July. The subpoenas were issued to more than 20 doctors and clinics nationwide as part of a government investigation into suspects accused of performing transgender procedures on minors or providing them with puberty blockers and cross-sex hormones, which are labeled by proponents as “gender affirming care.”

Recommended Stories

House GOP expands antisemitism investigation into UC system with sweeping documen

See Full Page